EUVIMEDEUVIMED entdecken
Open Access

Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15‐Year Single‐Center Analysis

Jotaro Yamamoto iD, Sho Ogura, Shinsuke Takagi, Takayuki Shinohara, Hirofumi Takano, Mika Kuno, Mizuki Haraguchi, Otoya Watanabe, Takashi Sakoh, Kyosuke Yamaguchi, Masayo Morishima, Kosei Kageyama und 18 weitere

Transplant Infectious Disease · 2026

DOI: 10.1111/tid.70216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Jotaro Yamamoto und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Toranomon Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Fusariosis, Antifungal Agents, Fusarium. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive fusariosis (IF) is a rare but often fatal mold infection in immunocompromised patients, particularly after allogeneic hematopoietic stem cell transplantation (HSCT). Despite antifungal prophylaxis and treatment, mortality remains high.

Methods

We retrospectively reviewed all allogeneic HSCT recipients for hematological malignancies at our center (2010–2024) and identified proven IF cases. Species identification was based on multigene sequencing, and antifungal susceptibility testing was performed.

Results

Among 2359 allogeneic HSCTs, 17 proven IF cases (7.2/1000) were identified. Patients more often had prior HSCT (58.8% vs. 19.8%, p = 0.002) and were transplanted in non‐complete remission (94.1% vs. 75.8%). Median onset was 19 days (range, 2–1011) posttransplant, with a median neutrophil count of 1/µL (range, 1–7097) at diagnosis; 64.7% were pre‐engraftment. Prophylaxis included micafungin ( n = 10), posaconazole ( n = 4), and voriconazole ( n = 3). Species: Fusarium solani complex ( n = 11), Fusarium dimerum complex ( n = 4), and Fusarium fujikuroi complex ( n = 2). All isolates had high micafungin MECs (> 16 µg/mL); the median amphotericin B MIC was 4 µg/mL, voriconazole MIC > 8 µg/mL. Median overall survival was 8 days; mortality reached 82.4% by Day 84. In univariate analysis, combination liposomal amphotericin B (L‐AMB) plus voriconazole ( p = 0.013) and neutrophil recovery ( p = 0.008) were associated with improved survival. No clear trends were noted in antifungal susceptibility between survivors and non‐survivors.

Conclusions

IF after allogeneic HSCT is rare but highly lethal. Despite the small sample size, outcomes were not clearly associated with MIC values. Early L‐AMB plus VRCZ and neutrophil recovery may be associated with improved survival. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationFusariosisAntifungal AgentsFusariumInvasive Fungal InfectionsHumansFemaleRetrospective StudiesMaleImmunocompromised HostTransplantation, HomologousAdultMiddle AgedAdolescentAmphotericin BYoung AdultMicrobial Sensitivity TestsVoriconazoleHematologic NeoplasmsMicafunginAgedTriazoles

Stichwörter der Autor:innen

Fusarium speciesallogeneic hematopoietic stem cell transplantationantifungal susceptibilityinvasive fusariosisneutrophil recovery

Substanzen

Antifungal AgentsAmphotericin BVoriconazoleliposomal amphotericin BMicafunginposaconazoleTriazoles

Autor:innen und Institutionen

  • Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
  • Center for Long-Term Follow-Up After Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan.
  • Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Department of Fungal Infection, National Institute of Infectious Diseases, Japan Institute of Health Security, Tokyo, Japan.
  • Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.

ORCID-Profile: Jotaro Yamamoto, Daisuke Kaji, Masahiro Abe

Zitieren

APA

Yamamoto, J., Ogura, S., Takagi, S., Shinohara, T., Takano, H., Kuno, M., Haraguchi, M., Watanabe, O., Sakoh, T., Yamaguchi, K., Morishima, M., Kageyama, K., Kaji, D., Taya, Y., Nishida, A., Kimura, M., Yamamoto, H., Koizumi, A., Abe, M., …, & Uchida, N. (2026). Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15‐Year Single‐Center Analysis. Transplant Infectious Disease. https://doi.org/10.1111/tid.70216

Vancouver

Yamamoto J, Ogura S, Takagi S, Shinohara T, Takano H, Kuno M, et al. Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15‐Year Single‐Center Analysis. Transplant Infectious Disease. 2026. doi:10.1111/tid.70216

BibTeX
@article{Yamamoto2026,
  author = {Yamamoto, Jotaro and Ogura, Sho and Takagi, Shinsuke and Shinohara, Takayuki and Takano, Hirofumi and Kuno, Mika and Haraguchi, Mizuki and Watanabe, Otoya and Sakoh, Takashi and Yamaguchi, Kyosuke and Morishima, Masayo and Kageyama, Kosei and Kaji, Daisuke and Taya, Yuki and Nishida, Aya and Kimura, Muneyoshi and Yamamoto, Hisashi and Koizumi, Ami and Abe, Masahiro and Hoshino, Yasutaka and Oiki, Sayoko and Horiguchi, Takanori and Umeyama, Takashi and Asano-Mori, Yuki and Yamamoto, Go and Wake, Atsushi and Araoka, Hideki and Miyazaki, Yoshitsugu and Taniguchi, Shuichi and Uchida, Naoyuki},
  title = {Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15‐Year Single‐Center Analysis},
  journal = {Transplant Infectious Disease},
  year = {2026},
  doi = {10.1111/tid.70216}
}
Kostenlos starten →